- Home
- Featured Publications
- Center Publications
- Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.
Citation | “Effects Of Liraglutide On Cardiovascular Outcomes In Type 2 Diabetes Patients With And Without Baseline Metformin Use: Post Hoc Analyses Of The Leader Trial.”. Diabetes Care, pp. e108-e110. . |
Center | North Carolina |
Author | Matthew J Crowley, Darren K McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A Saevereid, Subodh Verma, John B Buse |
Year of Publication |
2020
|
Journal |
Diabetes care
|
Volume |
43
|
Issue |
9
|
Number of Pages |
e108-e110
|
Date Published |
09/2020
|
ISSN Number |
1935-5548
|
DOI |
10.2337/dc20-0437
|
Alternate Journal |
Diabetes Care
|
PMID |
32647053
|
PMCID |
PMC7440910
|
Download citation |